Melanoma Matters

Ep 54: All things MSLT with Mark Faries

Listen Later

Summary

In this episode of Melanoma Matters, hosts Sapna Patel and James Larkin welcome surgical oncologist Mark Faries to discuss the evolution of surgical practices in melanoma, particularly focusing on sentinel lymph node biopsy and the implications of recent clinical trials. They explore the historical context of lymph node surgeries, the significance of nomograms in predicting patient outcomes, and the latest NCCN guidelines regarding clinic l stage II melanoma. They also delve into the emerging role of neoadjuvant therapies and the planned MSLT-3 trial, exploring the balance between effective treatment and minimizing surgical interventions. The

discussion highlights the importance of staging information and the potential immunosuppressive effects of surgery, concluding with reflections on the
collaborative nature of oncology care.


Takeaways

  • The significance and historical context of sentinel lymph node biopsy in melanoma treatment.
  • NCCN recommendations are evolving regarding sentinel lymph node biopsies.
  • Neoadjuvant therapies are changing the surgical landscape.
  • MSLT-3 aims to explore less invasive surgical options.
  • Surgery has immunosuppressive effects that need consideration.
  • Accurate staging information is a factor in decisions about treatment.
  • Collaboration between surgical and medical oncologists is fun!

    • Keywords

    melanoma, surgical oncology, lymph nodes, sentinel lymph node biopsy, MSLT trials, adjuvant therapy, nomograms, NCCN guidelines, neoadjuvant therapy, immune suppression


    Titles

    Navigating Melanoma: Insights from Surgical Oncology

    The Evolution of Sentinel Lymph Node Surgery


    Sound Bites

    "No tumor is resistant to formaldehyde."

    "Surgery is the gold standard."

    "We need that staging information."


    Chapters

    00:00 Introduction and Welcome to Special Guest, Mark Faries

    06:06 The Evolution of Lymph Node Surgery

    09:07 MSLT Trials: Insights and Outcomes

    11:59 Current Practices in Sentinel Lymph Node Biopsy

    15:02 Adjuvant Therapy and Its Implications

    21:09 NCCN Guidelines and Clinical Stage II Disease

    24:19 MSLT-3: A New Era in Melanoma Surgery

    26:52 The Role of Immune Suppression with Surgery

    ...more
    View all episodesView all episodes
    Download on the App Store
    Melanoma MattersBy Melanoma Matters Pod
    • 3.7
    • 3.7
    • 3.7
    • 3.7
    • 3.7

    3.7

    3 ratings

    More shows like Melanoma Matters

    View all
    Pod Save America by Crooked Media

    Pod Save America

    87,790 Listeners